NCT06044129

Brief Summary

The aim of this study was to use MRI imaging to accurately scan the pregnant woman's pelvis and fetal skull, build a 3D model of them, and combine with artificial intelligence to develop an accurate tool to predict the success rate of vaginal delivery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jan 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Jan 2024Dec 2026

First Submitted

Initial submission to the registry

September 12, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

September 21, 2023

Status Verified

September 1, 2023

Enrollment Period

2.7 years

First QC Date

September 12, 2023

Last Update Submit

September 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The mode of delivery

    Vaginal or cesarean delivery in the end

    during delivery

Study Arms (1)

Vaginal trial labor group

Device: Mri scan of fetal head and pelvis

Interventions

The pelvic parameters and fetal head parameters of pregnant women were measured by MRI, including pelvic entrance plane, middle pelvic plane, pelvic outlet plane, pubic arch Angle, double parietal diameter, occipitofrontal diameter, and suboccipital fontanel diameter.

Vaginal trial labor group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Full-term single live pregnant women who gave birth in the Department of Obstetrics of the Second Affiliated Hospital of Wenzhou Medical University from January 1, 2024 to December 31, 2026 were selected as the study population

You may qualify if:

  • Full-term.
  • Single fetus, head first.
  • Pregnant women have vaginal couvade wishes.
  • Complete clinical data of pregnant women.

You may not qualify if:

  • Pregnancy with serious medical and surgical diseases.
  • Abnormal fetal position (such as transverse, breech, etc.).
  • Twin or multiple pregnancies.
  • Vaginal couvade contraindications such as placenta previa.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, 325027, China

Location

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2023

First Posted

September 21, 2023

Study Start

January 1, 2024

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

September 21, 2023

Record last verified: 2023-09

Locations